SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Hempacco Co., Inc. – ‘8-K’ for 8/29/22

On:  Friday, 9/2/22, at 4:15pm ET   ·   For:  8/29/22   ·   Accession #:  1477932-22-6638   ·   File #:  1-41487

Previous ‘8-K’:  None   ·   Next:  ‘8-K’ on 2/2/23 for 1/30/23   ·   Latest:  ‘8-K’ on 3/28/24 for 3/8/24   ·   9 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/02/22  Hempacco Co., Inc.                8-K:1,5,9   8/29/22   21:1.1M                                   Discount Edgar/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     33K 
 2: EX-1.1      Underwriting Agreement or Conflict Minerals Report  HTML    336K 
 3: EX-4.1      Representative's Warrant                            HTML     75K 
 4: EX-10.1     Indemnification Agreement                           HTML     56K 
 5: EX-10.2     Indemnification Agreement                           HTML     53K 
 6: EX-10.3     Indemnification Agreement                           HTML     54K 
 7: EX-10.4     Indemnification Agreement                           HTML     53K 
 8: EX-10.5     Indemnification Agreement                           HTML     53K 
 9: EX-10.6     Indemnification Agreement                           HTML     53K 
10: EX-10.7     Independent Director Agreement                      HTML     33K 
16: R1          Cover                                               HTML     45K 
19: XML         IDEA XML File -- Filing Summary                      XML     16K 
17: XML         XBRL Instance -- hemp_8k_htm                         XML     16K 
18: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
13: EX-101.CAL  XBRL Calculations -- hemp-20220829_cal               XML      9K 
15: EX-101.DEF  XBRL Definitions -- hemp-20220829_def                XML     12K 
12: EX-101.LAB  XBRL Labels -- hemp-20220829_lab                     XML     43K 
14: EX-101.PRE  XBRL Presentations -- hemp-20220829_pre              XML     30K 
11: EX-101.SCH  XBRL Schema -- hemp-20220829                         XSD     20K 
20: JSON        XBRL Instance as JSON Data -- MetaLinks               11±    18K 
21: ZIP         XBRL Zipped Folder -- 0001477932-22-006638-xbrl      Zip    209K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C: 
 i 0001892480 i false00018924802022-08-292022-08-29iso4217:USDxbrli:sharesiso4217:USDxbrli:shares

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.

_____________________

 

FORM  i 8-K

_____________________

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported):  i August 29, 2022

 

 i Hempacco Co., Inc.

(Exact name of registrant as specified in its charter)

 

 i 001-41487

 i 83-4231457

(Commission File Number)

(IRS Employer Identification Number)

 

 i 9925 Airway Road,  i San Diego,  i CA

 

 i 92154

(Address of Principal Executive Offices)

 

(Zip Code)

 

( i 619)  i 779-0715

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 i      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 i      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 i      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR240.14d-2(b))

 i      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

 

Trading Symbol(s)

 

Name of Each Exchange on Which Registered

 i Common Stock, par value $0.001

 

 i HPCO

 

The  i Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company  i 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

On August 29, 2022, Hempacco Co., Inc. (the “Company”) entered into an underwriting agreement with Boustead Securities, LLC, as representative (the “Representative”) of the underwriters (the “Underwriters”) in connection with the initial public offering of the Company (the “IPO”). The Underwriting Agreement provides for the offer and sale of 1,000,000 shares of the Company’s common stock, par value $0.001 (the “Common Stock”) at a price to the public of $6.00 per share (the “Offering”). In connection therewith, the Company agreed to issue 70,000 warrants to purchase shares of Common Stock, exercisable from September 1, 2022, through August 29, 2027, and initially exercisable at $9.00 per share subject to adjustment as provided therein (the “Representative’s Warrants”). The Company also granted the Underwriters an option for a period of 45 days to purchase up to an additional 150,000 shares of Common Stock. The Offering is being made pursuant to a Registration Statement on Form S-1 (File No. 333-263805) (the “Registration Statement”), which was declared effective by the Securities and Exchange Commission on August 29, 2022.

 

The Underwriting Agreement includes customary representations, warranties and covenants by the Company. It also provides that the Company will indemnify the Underwriters against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”), or contribute to payments the Underwriter may be required to make because of any of those liabilities.

 

On September 1, 2022, the Offering was completed. At the closing, the Company (i) sold 1,000,000 shares of Common Stock for total gross proceeds of $6,000,000, and (ii) issued the Representative’s Warrants. After deducting the underwriting commission and expenses, the Company received net proceeds of $5,484,015.

 

Upon effectiveness of the Registration Statement, on August 29, 2022, the Company also entered into indemnification agreements (collectively the “Indemnification Agreements”) with the Company’s executive officers and directors (Sandro Piancone, Neville Pearson, Jorge Olson, Stuart Titus, Jerry Halamuda, and Miki Stephens) providing, among other things, for (i) indemnification of the officers and directors to the fullest extent permitted by law and the Company’s articles of incorporation and bylaws against any and all expenses, judgments, fines, penalties and amounts paid in settlement of any claim; and (ii) the advancement or payment of all expenses to the indemnitee and for reimbursement to the Company if it is found that such indemnitee is not entitled to such indemnification under applicable law and the Company’s articles of incorporation and bylaws.

 

Finally, in connection with the effectiveness of the Registration Statement and the appointment of Miki Stephens as a member of the Board of Directors (as disclosed in Item 5.02 herein), effective as of September 29, 2022, the Company entered an independent director agreement (the “Independent Director Agreement”) with Ms. Stephens, pursuant to which Ms. Stephens would serve as director of the Company until removal or resignation, and with compensation terms reserved for future determination by the Company and Ms. Stephens.

 

The foregoing descriptions of the Underwriting Agreement, Representative’s Warrants, Indemnification Agreements, and Indemnification Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of the Underwriting Agreement, Representative’s Warrants, Indemnification Agreements, and Independent Director Agreement attached hereto as Exhibit 1.1, Exhibit 4.1, Exhibit 10.1-10.6, and Exhibit 10.7, respectively, and incorporated herein by reference.

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

The disclosure in Item 1.01 is incorporated by reference into this Item 5.02. Upon effectiveness of the Registration Statement, on August 29, 2022, Miki Stephens was appointed a member of the Company’s Board of Directors (the “Board”). Ms. Stephens will be a member of the Company’s Audit Committee and Compensation Committee, and will serve as the Chair of the Company’s Nominating and Corporate Governance Committee.

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit No.

 

Description

 

 

 

1.1

 

Underwriting Agreement, dated August 29, 2022, by and between Hempacco Co., Inc. and Boustead Securities, LLC

4.1

 

Representative’s Warrant

10.1

 

Indemnification Agreement, dated August 29, 2022, by and between Hempacco Co., Inc. and Sandro Piancone

10.2

 

Indemnification Agreement, dated August 29, 2022, by and between Hempacco Co., Inc. and Neville Pearson

10.3

 

Indemnification Agreement, dated August 29, 2022, by and between Hempacco Co., Inc. and Jorge Olson

10.4

 

Indemnification Agreement, dated August 29, 2022, by and between Hempacco Co., Inc. and Stuart Titus

10.5

 

Indemnification Agreement, dated August 29, 2022, by and between Hempacco Co., Inc. and Jerry Halamuda

10.6

 

Indemnification Agreement, dated August 29, 2022, by and between Hempacco Co., Inc. and Miki Stephens

10.7

 

Independent Director Agreement, dated August 29, 2022, by and between Hempacco Co., Inc. and Miki Stephens

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL Document)

 

 
2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunder duly authorized.

 

 

HEMPACCO CO., INC.

 

 

 

 

Dated: September 2, 2022

By:

/s/ Sandro Piancone

 

 

Sandro Piancone

 

 

 

Chief Executive Officer

 

 

 
3

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
8/29/27
9/29/22
Filed on:9/2/22
9/1/223
For Period end:8/29/223,  8-A12B,  CERT,  EFFECT
 List all Filings 


9 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/29/24  Hempacco Co., Inc.                S-1                   66:8.8M                                   Discount Edgar/FA
11/20/23  Hempacco Co., Inc.                10-Q        9/30/23   59:4.4M                                   Discount Edgar/FA
 8/14/23  Hempacco Co., Inc.                10-Q        6/30/23   60:4M                                     Discount Edgar/FA
 7/05/23  Hempacco Co., Inc.                10-Q        3/31/23   60:3.4M                                   Discount Edgar/FA
 5/15/23  Hempacco Co., Inc.                10-K       12/31/22   66:5.4M                                   Discount Edgar/FA
 2/03/23  Hempacco Co., Inc.                S-1                   69:7.9M                                   Discount Edgar/FA
12/22/22  Hempacco Co., Inc.                DRS2/06/23    1:2M                                     Discount Edgar/FA
11/17/22  Hempacco Co., Inc.                10-Q/A      9/30/22   58:4.1M                                   Discount Edgar/FA
11/15/22  Hempacco Co., Inc.                10-Q        9/30/22    5:685K                                   Discount Edgar/FA
Top
Filing Submission 0001477932-22-006638   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 7:36:47.1am ET